These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26483439)

  • 1. Question 2: Unexpected neutropenia in a febrile, but immunocompetent, child.
    Knight K
    Arch Dis Child; 2015 Nov; 100(11):1093-5. PubMed ID: 26483439
    [No Abstract]   [Full Text] [Related]  

  • 2. The Risk of Serious Bacterial Infection in Neutropenic Immunocompetent Febrile Children.
    Barg AA; Kozer E; Mordish Y; Lazarovitch T; Kventsel I; Goldman M
    J Pediatr Hematol Oncol; 2015 Aug; 37(6):e347-51. PubMed ID: 25929615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of febrile neutropenia].
    Urabe A
    Rinsho Ketsueki; 2009 Feb; 50(2):69-72. PubMed ID: 19265296
    [No Abstract]   [Full Text] [Related]  

  • 4. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
    El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Problems and proposals for revision of the Japanese guideline for febrile neutropenia].
    Yoshida M
    Rinsho Ketsueki; 2011 Apr; 52(4):182-9. PubMed ID: 21566403
    [No Abstract]   [Full Text] [Related]  

  • 6. Important aspects of cost-effectiveness analysis in febrile neutropenia.
    Karthaus M; Boehme A; Ganser A; Juergens H
    Infection; 1999; 27(6):372-5. PubMed ID: 10624602
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk assessment and risk-based therapy in febrile neutropenic patients.
    Rolston KV
    Eur J Clin Microbiol Infect Dis; 1998 Jul; 17(7):461-3. PubMed ID: 9764547
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings of the 4th International Symposium on Febrile Neutropenia. December 15-17, 1999.
    Int J Antimicrob Agents; 2000 Oct; 16(2):83-187. PubMed ID: 11203263
    [No Abstract]   [Full Text] [Related]  

  • 9. Zinc supplement may be effective in febrile neutropenia.
    Zareifar S; Sharifian M
    Indian J Pediatr; 2007 Oct; 74(10):964-5. PubMed ID: 17978463
    [No Abstract]   [Full Text] [Related]  

  • 10. Significance of C-reactive protein during febrile neutropenia in pediatric malignancies.
    Avabratha KS; Rau AT; Venkataravanamma P; Rau A
    Indian Pediatr; 2009 Sep; 46(9):797-9. PubMed ID: 19430077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fever and neutropenia: bacterial etiology revealed by serological methods.
    Riikonen P; Leinonen M; Jalanko H; Hovi L; Saarinen UM
    Acta Paediatr; 1993 Apr; 82(4):355-9. PubMed ID: 8318802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal therapy for febrile neutropenia: issues in clinical trial design.
    Marr KA
    Curr Opin Investig Drugs; 2004 Feb; 5(2):202-7. PubMed ID: 15043395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance study of bacteraemic episodes in febrile neutropenic children.
    Ariffin H; Navaratnam P; Lin HP
    Int J Clin Pract; 2002 May; 56(4):237-40. PubMed ID: 12074201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased interleukin-10 levels correlate with bacteremia and sepsis in febrile neutropenia pediatric oncology patients.
    Urbonas V; Eidukaitė A; Tamulienė I
    Cytokine; 2012 Mar; 57(3):313-5. PubMed ID: 22189417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia.
    Noel GJ
    J Pediatr; 1999 Sep; 135(3):399. PubMed ID: 10523149
    [No Abstract]   [Full Text] [Related]  

  • 16. Treating low-risk febrile neutropenia: Jenny's story.
    Phillips R; Skinner R; Chisholm JC
    Arch Dis Child; 2007 Jan; 92(1):7-8. PubMed ID: 17185442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Microbiological isolates in patients with febrile neutropenia and hematological neoplasias].
    Figuera Esparza M; Carballo M; Silva M; Figueredo A; Avilán J
    Rev Esp Quimioter; 2006 Sep; 19(3):247-51. PubMed ID: 17099792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiology of febrile neutropenia: European data on incidence and resistance.
    Picazo JJ
    Int J Hematol; 1998 Oct; 68 Suppl 1():S35-8. PubMed ID: 9838743
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evidence-based management of neutropenia and fever].
    Ishiguro H; Fung MC; Sakata T; Morizane T; Adachi S
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1365-71. PubMed ID: 14518423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-sepsis prophylaxis and empirical treatment of febrile patients with neutropenia in acute leukaemia.
    Advani SH; Ahuja HG; Pai MR; Saikia T; Gopal R; Nair CN
    J Assoc Physicians India; 1986 Aug; 34(8):559-62. PubMed ID: 3466893
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.